Assertio Therapeutics, Inc. buy PlusUltra
Start price
13.03.20
/
50%
€0.71
Target price
22.05.20
€3.00
Performance (%)
2.13%
End price
22.05.20
-
Summary
This prediction ended on 22.05.20 with a price of -. With a performance of 2.13%, the BUY prediction by PlusUltra for Assertio Therapeutics, Inc. closed with a slight gain. PlusUltra has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Assertio Therapeutics, Inc. | -2.667% | -2.667% | -87.813% | -92.074% |
| iShares Core DAX® | 1,60 % | -7,45 % | 3,04 % | 46,26 % |
| iShares Nasdaq 100 | -0,73 % | -1,86 % | 15,42 % | 72,33 % |
| iShares Nikkei 225® | 1,30 % | -6,80 % | 34,31 % | 52,28 % |
| iShares S&P 500 | -0,39 % | -2,34 % | 9,91 % | 55,10 % |
Comments by PlusUltra for this prediction
In the thread Discuss Assertio Therapeutics, Inc.
Buy with target price 3.0